Clinical trial
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer…
NCT00075855 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00075855 |
|---|---|
| Title | Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors |
| Official title | The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer Survivor, Sexual Dysfunction, Sexuality and Reproductive Issues, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | therapeutic testosterone, placebo |
| Enrollment | 150 |
| Start date | Apr 1, 2004 |
| Primary completion | May 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jan 13, 2004 |
| Last update posted | Jul 13, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: